Goss, G. D., Darling, G. E., Westeel, V., Nakagawa, K., Massuti, B., Perrone, F., McLachlan, S., Kang, J. H., Wu, Y., Dingemans, A. C., Dziadziuszko, R., Greillier, L., Okada, M., Audigier-Valette, C., Sugawara, S., Nadal, E., Catino, A., Toffart, A., Mitsudomi, T., Whittom, R., Domine, M., Yamamoto, N., Molinier, O., Morin, F., Bradbury, P. A., Stockler, M. R., Ding, K., O'Callaghan, C. J. (2026). Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01828